NCT06046534 Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs. Status COMPLETED Phase N/A
NCT06045975 Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06042049 A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab Status COMPLETED Phase PHASE3
NCT06040099 A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06040086 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06039683 A Multicountry, Multicentre, Non-interventional, Retrospective Study to Determine Real-world Treatment Patterns and Associated Outcomes After First Line Osimertinib in Patients With Advanced and Metastatic NSCLC EGFRm in the GCC Region Status COMPLETED Phase N/A
NCT06034743 A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Status COMPLETED Phase PHASE3
NCT06023589 A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma Status RECRUITING Phase PHASE3
NCT06020014 Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA Status COMPLETED Phase PHASE2
NCT06017297 Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma Status WITHDRAWN Phase PHASE2
NCT06015737 A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06008353 A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06008093 A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06005493 Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05998837 GLUcose Transport and REnalPROtection in Chronic Kidney Disease Status COMPLETED Phase PHASE2/PHASE3
NCT05992519 Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma Status COMPLETED Phase N/A
NCT05984277 A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE3